In addition, upregulation of NR3C4 can be used as potential biomarker for type 2 diabetes whereas downregulation of two NRs including NR3C3 and NR4A3 can only be used as biomarkers for diabetes with rheumatoid arthritis as a complication. Here, NR4A3 is linked to type 2 diabetes mellitus.